Central Versus Peripheral Cardiovascular Risk in Metabolic Syndrome

Frontiers in Physiology - Switzerland
doi 10.3389/fphys.2012.00038
Full Text
Abstract

Available in full text

Categories
Physiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Novel Cardiovascular Risk Biomarkers in Metabolic Syndrome

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

C-Peptide Versus Insulin: Relationships With Risk Biomarkers of Cardiovascular Disease in Metabolic Syndrome in Young Arab Females

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2012English

Metabolic Syndrome and Risk Factors for Cardiovascular Disease: Are Nonagenarians Protected?

AGE
2009English

Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

Physical Activity and Metabolic Cardiovascular Syndrome

British Journal of Nutrition
MedicineNutritionDietetics
1998English

eNOS, Metabolic Syndrome and Cardiovascular Disease

Trends in Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2009English

Effect of BMI on Cardiovascular and Metabolic Syndrome Risk Factors in an Appalachian Pediatric Population

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2014English

Capacity Adiposity Indices to Identify Metabolic Syndrome in Subjects With Intermediate Cardiovascular Risk (MARK Study)

PLoS ONE
Multidisciplinary
2019English

Metabolic Acidosis and Cardiovascular Disease Risk in CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy